| LINE ITEM (USD / %) | FY 2025
FILED 2026-06-28 | FY 2024
FILED 2025-06-29 | FY 2023
FILED 2023-07-02 |
|---|---|---|---|
| Revenue (Total Sales) | $1.50B | $1.69B | $2.02B |
| YoY Revenue Growth % | -10.8% | -16.5% | — |
| Gross Profit | $571.3M | $652.3M | — |
| Gross Margin % | 38.0% | 38.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$127.1M | -$204.8M | -$35.0M |
| Operating Margin % | -8.5% | -12.2% | -1.7% |
| Net Income (GAAP) | -$134.8M | -$200.0M | -$44.7M |
| EBITDA (Normalized) | -$102.1M | -$171.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $18.3M | -$26.4M | $115.4M |
| Capital Expenditures (CapEx) | $31.3M | $41.5M | — |
| Free Cash Flow (FCF) | -$13.0M | -$67.8M | $115.4M |
| FCF Margin % | -0.9% | -4.0% | 5.7% |
| Return on Invested Capital (ROIC %) | -45.0% | -39.9% | — |
| Cash & Short-Term Equivalents | $193.3M | $247.2M | — |
| Total Debt (Short + Long Term) | $123.5M | $157.5M | — |
| Total Stockholders' Equity | $289.7M | $495.1M | — |